Biotechnology

Pharmaceuticals Clinical Trials Drug Development Clinical Research Research and Development Startups Pharmaceutical Companies Pharmaceutical Industry Acquisitions Biopharmaceuticals

Humacyte Raises $20 Million in Direct Offering and Lands Saudi Symvess Purchase Pact

The company directs funds toward near-term hemodialysis milestones.

Artelo Secures Fully Funded Investigator-Led Glaucoma Trial With Belfast Health Trust

AIM ImmunoTech Secures Final Japan Patent for Ampligen Checkpoint-Inhibitor Cancer Therapy

Atrogi Begins Dosing in 8-Week Human Study of GRK2-Biased β2 Agonist ATR-258

Codexis Posts Q4 Beat on Merck Deal, Sets 2026 Outlook

BioNTech Founders to Exit This Year to Launch New mRNA Company as Stock Slumps on Weak Outlook

KALA BIO Says First AI Agent Ships in Two Weeks as Shares Soar Pre-Market

Xenon to Present Topline X-TOLE2 Phase 3 Results in Focal Onset Seizures at 8 A.M. ET Today

Iovance Shares Hit Record After UBS Doubles Price Target

FDA Demands Placebo-Controlled Trial for UniQure’s Huntington’s Gene Therapy

Ocugen Completes Phase III Enrollment for OCU400 and Targets Q3 2026 Rolling BLA

Investor Law Firms Rally uniQure Case as April 13 Lead-Plaintiff Deadline Nears

Can-Fite's Namodenoson Clears Phase IIa Safety Bar in Pancreatic Cancer

FDA to Review Moderna’s Flu Shot as Shares Rally on Earnings Beat

Astellas–Vir Prostate Cancer Alliance Launches With New Data as VIR Stock Surges

Gilead to Acquire Arcellx for Up to $7.8 Billion to Gain Full Control of CAR-T Anito-Cel

Krystal Biotech Posts Strong Q4 as VYJUVEK Hits $107 Million, Pivots 2026 Growth to Ex‑U.S. Markets

Compass Pathways’ Psilocybin Therapy Hits Phase 3 Goal in Treatment-Resistant Depression

FDA Rejects Filing of Moderna’s mRNA Flu Vaccine Over Comparator Dispute

FDA Rejects Disc Medicine’s Bitopertin for EPP After Questioning Surrogate Endpoint